The Clinical Effect of Ketorolac Tromethamine Used for PCIA in Breast Cancer

曾文斌,韩丽春,党晓东,李燕琴
DOI: https://doi.org/10.16833/j.cnki.jbmc.2012.04.027
2012-01-01
Abstract:Objective: To observe the clinic effect and adverse reaction of ketorolac tromethamine used for patient controlled intravenous analgesia(PCIA) in breast cancer.Methods: 60 patients for operation on breast,ASAⅠ-Ⅱ,aged between 36 and 61,were randomly divided into two groups(Group A and Group B) and the fentanyl was used for PCIA in group A,the ketorolac tromethamine in group B.VAS and RSS scores of all the subjects were kept at different time points of 2 h,4 h,8 h,12 h,24 h and 48 h after operation with PCIA(maintenance dose 2 mL/h,PCA 0.5mL,interval time 15 min).Results: there was no significant difference between the two groups in VAS and RSS score(P>0.05),and there was less adverse reaction in group B than in group A,but with no statistical difference(P>0.05).Conclusion: ketorolac tromethamine can be used for PCIA in breast cancer,safe and effective.
What problem does this paper attempt to address?